Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

314 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

NCT00774397

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 1220.5.0001 Boehringer Ingelheim Investigational Site San Francisco, California, United States

1220.5.0008 Boehringer Ingelheim Investigational Site San Francisco, California, United States

1220.5.0005 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States

1220.5.0006 Boehringer Ingelheim Investigational Site Lutherville, Maryland, United States

View all 100 locations

View Trial Details

Completed

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

NCT01908660

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +32 more
Locations: Hospital Universitario de Valme Seville, Spain

View Trial Details

Completed

PegIntron Injection Surveillance Plan (Study P04123)

NCT00723931

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

NCT00709059

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

NCT00723892

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

NCT00724464

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

ADHEPTA Study: Adherence Questionnaire in Hepatitis C

NCT00998621

Conditions: Behavior, Blood-Borne Infections, Chronic Disease, +30 more
Locations: Hospital del Mar Barcelona, Spain

View Trial Details

Completed

Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)

NCT00727311

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)

NCT00726557

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +18 more
Locations: Not specified

View Trial Details

Completed

Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)

NCT00725205

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details